Economic Evaluation of New Antidiabetic Agents Among Type 2 Diabetes Mellitus Patients in Jordan

dc.contributor.advisorSándor, János
dc.contributor.advisorFraihat, Nadine
dc.contributor.authorAlomoush, Bushra
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentBalázs, Ádám
dc.contributor.opponentSzőllősi, Gergő
dc.date.accessioned2021-01-05T08:44:03Z
dc.date.available2021-01-05T08:44:03Z
dc.date.created2020
dc.description.abstractThis thesis is a retrospective study which aimed to determine and analyze cost-effectiveness (CE) of newer generations of antidiabetic agents compared to current interventions used in Type 2 Diabetes Mellitus patients in Jordan.hu_HU
dc.description.coursenépegészségügyi MSchu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent41hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/300791
dc.language.isoenhu_HU
dc.subjectEconomic evaluationhu_HU
dc.subjectType 2 Diabetes Mellitushu_HU
dc.subjectNew generation of Antidiabeticshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Népegészségügyhu_HU
dc.titleEconomic Evaluation of New Antidiabetic Agents Among Type 2 Diabetes Mellitus Patients in Jordanhu_HU
Fájlok